share_log

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K：诺和诺德-股票回购计划
美股SEC公告 ·  08/19 09:22
Moomoo AI 已提取核心信息
Novo Nordisk A/S, a leading global healthcare company, has reported on the progress of its share repurchase program. The program, which began on February 6, 2024, aims to buy back shares worth up to DKK 20 billion over a 12-month period. As part of this initiative, a specific share repurchase plan was initiated on August 7, 2024, targeting the repurchase of B shares for an amount up to DKK 2.4 billion by November 4, 2024. Since the last announcement on August 12, 2024, Novo Nordisk has acquired 335,187 B shares at an average price of DKK 879.32, amounting to a total transaction value of DKK 298,612,988. These transactions are separate from the company's incentive programs, which resulted in a net transfer of 14,129 B shares from August 12 to August 16, 2024. Novo Nordisk now holds 12,730,944 B shares as treasury shares, representing 0.3% of the share capital. The company's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
Novo Nordisk A/S, a leading global healthcare company, has reported on the progress of its share repurchase program. The program, which began on February 6, 2024, aims to buy back shares worth up to DKK 20 billion over a 12-month period. As part of this initiative, a specific share repurchase plan was initiated on August 7, 2024, targeting the repurchase of B shares for an amount up to DKK 2.4 billion by November 4, 2024. Since the last announcement on August 12, 2024, Novo Nordisk has acquired 335,187 B shares at an average price of DKK 879.32, amounting to a total transaction value of DKK 298,612,988. These transactions are separate from the company's incentive programs, which resulted in a net transfer of 14,129 B shares from August 12 to August 16, 2024. Novo Nordisk now holds 12,730,944 B shares as treasury shares, representing 0.3% of the share capital. The company's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
全球领先的医疗保健公司诺和诺德曾宣布了其股票回购计划的进展情况。该计划于2024年2月6日启动，旨在在12个月内回购价值高达200亿丹麦克朗的股票。作为该计划的一部分，特定的股票回购计划于2024年8月7日启动，旨在在2024年11月4日之前，以高达24亿丹麦克朗的金额回购B股。自2024年8月12日上次公告以来，诺和诺德已以平均每股879.32丹麦克朗的价格，收购了3351870亿股，总交易金额为298,612,988丹麦克朗。这些交易是与该公司的激励计划分开的，该计划在2024年8月12日至8月16日期间，净转移了141290亿股。诺和诺德现持有127309440亿股作为库存股，占股本的0.3％。该公司的股票在纳斯达克哥本哈根交易，并且在纽约证券交易所上市的美国存托凭证也同样如此。
全球领先的医疗保健公司诺和诺德曾宣布了其股票回购计划的进展情况。该计划于2024年2月6日启动，旨在在12个月内回购价值高达200亿丹麦克朗的股票。作为该计划的一部分，特定的股票回购计划于2024年8月7日启动，旨在在2024年11月4日之前，以高达24亿丹麦克朗的金额回购B股。自2024年8月12日上次公告以来，诺和诺德已以平均每股879.32丹麦克朗的价格，收购了3351870亿股，总交易金额为298,612,988丹麦克朗。这些交易是与该公司的激励计划分开的，该计划在2024年8月12日至8月16日期间，净转移了141290亿股。诺和诺德现持有127309440亿股作为库存股，占股本的0.3％。该公司的股票在纳斯达克哥本哈根交易，并且在纽约证券交易所上市的美国存托凭证也同样如此。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息